Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010
|
| In: |
Circulation
Year: 2010, Jahrgang: 121, Heft: 23, Pages: 2575-2583 |
| ISSN: | 1524-4539 |
| Online-Zugang: | Verlag, Volltext: http://circ.ahajournals.org/content/121/23/2575.full
|
| Verfasserangaben: | Peter B. Berger ... Werner Hacke ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1486979661 | ||
| 003 | DE-627 | ||
| 005 | 20230426164857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 141113s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1161/CIRCULATIONAHA.109.895342 |2 doi | |
| 035 | |a (DE-627)1486979661 | ||
| 035 | |a (DE-576)416979661 | ||
| 035 | |a (DE-599)BSZ416979661 | ||
| 035 | |a (OCoLC)1340654633 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease |b results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |c Peter B. Berger ... Werner Hacke ... |
| 264 | 1 | |c 2010 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.11.2014 | ||
| 700 | 1 | |a Berger, Peter B. |0 (DE-588)1060852012 |0 (DE-627)802903185 |0 (DE-576)416979432 |4 oth | |
| 700 | 1 | |a Hacke, Werner |d 1948- |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 oth | |
| 773 | 0 | 8 | |i In |t Circulation |d Philadelphia, Pa. : Lippincott, Williams & Wilkins, 1950 |g 121(2010), 23, Seite 2575-2583 |h Online-Ressource |w (DE-627)265784670 |w (DE-600)1466401-X |w (DE-576)074891189 |x 1524-4539 |7 nnas |a Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |
| 773 | 1 | 8 | |g volume:121 |g year:2010 |g number:23 |g pages:2575-2583 |g extent:9 |a Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial |
| 856 | 4 | 0 | |u http://circ.ahajournals.org/content/121/23/2575.full |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20141114 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 910000 |d 911100 |e 910000PH12021699X |e 911100PH12021699X |k 0/910000/ |k 1/910000/911100/ |p 8 | ||
| 999 | |a KXP-PPN1486979661 |e 2820829201 | ||
| BIB | |a Y | ||
| SER | |a newspaper | ||
| JSO | |a {"physDesc":[{"extent":"9 S."}],"language":["eng"],"id":{"eki":["1486979661"],"doi":["10.1161/CIRCULATIONAHA.109.895342"]},"recId":"1486979661","title":[{"subtitle":"results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","title":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease","title_sort":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease"}],"person":[{"display":"Berger, Peter B.","family":"Berger","role":"oth","given":"Peter B."},{"role":"oth","given":"Werner","display":"Hacke, Werner","family":"Hacke"}],"note":["Gesehen am 13.11.2014"],"type":{"bibl":"article-newspaper","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"relHost":[{"note":["Gesehen am 10.10.2025"],"title":[{"subtitle":"an official journal of the American Heart Association","title":"Circulation","title_sort":"Circulation"}],"type":{"media":"Online-Ressource","bibl":"newspaper"},"language":["eng"],"id":{"issn":["1524-4539"],"zdb":["1466401-X"],"eki":["265784670"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"265784670","part":{"pages":"2575-2583","volume":"121","text":"121(2010), 23, Seite 2575-2583","issue":"23","extent":"9","year":"2010"},"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Heart Association","role":"isb"}],"origin":[{"dateIssuedKey":"1950","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","publisher":"Lippincott, Williams & Wilkins ; Ovid","dateIssuedDisp":"1950-"}],"disp":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialCirculation","pubHistory":["1.1950 -"]}],"name":{"displayForm":["Peter B. Berger ... Werner Hacke ..."]}} | ||
| SRT | |a BLEEDINGCO2010 | ||